Cumberland Pharmaceuticals (CPIX) Profit After Tax (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Profit After Tax across 17 years of filings, most recently posting -$4.3 million for Q2 2026.

• In Q2 2026, Profit After Tax fell 42.63% year-over-year to -$4.3 million; the TTM figure through Jun 2026 stood at -$10.9 million (down 110.49% YoY), while the FY2025 annual figure was -$2.9 million, up 55.79% from the prior year.
• Profit After Tax came in at -$4.3 million for Q2 2026 at Cumberland Pharmaceuticals, down from -$3.3 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $1.2 million in Q1 2025 to a low of -$6.3 million in Q4 2023.
• Average Profit After Tax over 5 years is -$1.7 million, with a median of -$1.5 million recorded in 2024.
• Year-over-year, Profit After Tax slumped 1112.71% in 2024 and surged 164.13% in 2025.
• Over 5 years, Profit After Tax stood at -$2.5 million in 2022, then slumped by 156.21% to -$6.3 million in 2023, then surged by 69.79% to -$1.9 million in 2024, then rose by 24.96% to -$1.4 million in 2025, then slumped by 199.33% to -$4.3 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$4.3 million in Q2 2026, -$3.3 million in Q1 2026, and -$1.4 million in Q4 2025.